Resources

At InterFinancial’s recent M&A Insiders event, we were fortunate enough to have Darren Stanley from Citadel Group discuss a few key learnings from his years across roles in the military, the IT industry, and most recently as Citadel Group’s Chief Executive Officer. Citadel’s M&A strategy is structured around the core purpose of keeping people safe. […]

We are pleased to make available our look back at M&A in 2017 and a forecast of what’s to come in 2018, including sector outlooks with the contributions of esteemed clients, senior advisors, and friends. Read the publication.

Clairfield International is pleased to announce that Clairfield has once again been ranked at the top of the league tables for financial advisors by Thomson Reuters. Clairfield International stands out among boutique investment banking firms in achieving high ranks alongside bulge-bracket banks, placed 17th in the small-cap segment worldwide and 12th in Europe by number of […]

In the final moments of 2017, InterFinancial helped secure an investment in Hall Contracting, the Australian-owned civil and marine contracting business, from Sydney-based private equity firm, Crescent Capital Partners. Hall is a third generation family business founded over 70 years ago. As part of their succession planning process, the shareholders were seeking an experienced partner […]

  Following a broad domestic and international search, with the assistance of our Clairfield partners, DZG Investments, the Australian subsidiary of the  Goubuli Group, a Chinese food and beverage company, has acquired an 80% stake in BJP Laboratories, a leading Australian contract manufacturer of listed medicines. InterFinancial assumed a lead advisory role on the transaction […]

Clairfield International has further expanded its global M&A presence through a new partnership in the United States with Atlanta-based investment bank Croft & Bender. Croft & Bender provides mergers and acquisitions, private capital-raising, and financial advisory services to middle-market and emerging growth companies. Croft & Bender will be exclusive partner for Clairfield in the United […]

Charm Health is Australia’s leading supplier of specialist medical oncology e-health systems, with its solutions used by leading public and private health providers of cancer care. OneVentures first invested in Charm Health in 2013 through OneVentures Innovation Fund I and has been instrumental in supporting the Charm Health team in increasing market share and reinforcing […]